AMJ Oncology 3.1 [Supplement 5] . 2026

In this issue

Experts in thoracic oncology from across the multidisciplinary team (MDT) explore the increasingly complex treatment landscape in metastatic EGFR-mutated non-small cell lung cancer (NSCLC), highlighting key factors and real-world challenges that influence clinical decision-making across the disease journey.